A Randomised Controlled Trial Of N-acetylcysteine For The Treatment Of Alcohol Use Disorder
Funder
National Health and Medical Research Council
Funding Amount
$1,294,923.00
Summary
We urgently require new treatment strategies. Alcohol misuse is a leading cause of preventable death yet treatment options are limited. We will undertake the first human trial of N-acetylcysteine (NAC) for the management of alcohol use disorder (NAC-AUD). The NAC-AUD project will evaluate the efficacy and cost-efficacy of NAC to reduce alcohol consumption. The results will generate high level clinical evidence for a safe new treatment for a common life threatening disease.
Defining The Clinical Role Of Topiramate In The Treatment Of Alcohol Dependence In Australia
Funder
National Health and Medical Research Council
Funding Amount
$718,836.00
Summary
We urgently require new strategies for the treatment of alcohol dependence. The effectiveness of currently approved alcohol medications is limited. Emerging data suggests that topiramate has robust effectiveness and that better medicine selection is possible for patients based on their genotype. We propose to conduct a double-blind randomised controlled trial to examine the clinical and cost effectiveness of topiramate using a genetically based personalised approach.
Mental Health First Aid Training In The Workplace: A Randomized Controlled Trial Of Online And Blended Modes
Funder
National Health and Medical Research Council
Funding Amount
$540,247.00
Summary
This project will evaluate the effects of Mental Health First Aid (MHFA) training, which aims to teach members of the public how to support people they know who are developing a mental health problem or are in a mental health crisis. Training will be offered to Victorian public servants to see whether it changes their knowledge, attitudes and helping behaviour. MHFA training will be delivered either online or as a blend of online with face-to-face teaching, and will be compared with online Red C ....This project will evaluate the effects of Mental Health First Aid (MHFA) training, which aims to teach members of the public how to support people they know who are developing a mental health problem or are in a mental health crisis. Training will be offered to Victorian public servants to see whether it changes their knowledge, attitudes and helping behaviour. MHFA training will be delivered either online or as a blend of online with face-to-face teaching, and will be compared with online Red Cross physical first aid training as a control.Read moreRead less
Improving Online Mental Health Programs: Tailored Assessment Meets Tailored Therapy
Funder
National Health and Medical Research Council
Funding Amount
$478,065.00
Summary
The proposed research will develop a personalised mental health program designed to address multiple mental health problems: major depression, anxiety disorders and substance use disorders, and suicidality. The program will increase efficiency and user engagement by tailoring content based on individual needs, context and preferences. Ongoing monitoring using new methods of assessment will allow a responsive and flexible approach to care.
Improving Treatment Responses For Co-occurring Mental And Substance Use Disorders
Funder
National Health and Medical Research Council
Funding Amount
$631,370.00
Summary
Mental and substance use disorders are two of Australia's most prevalent and burdensome health conditions, and they frequently co-occur. My program of research aims to improve our limited understanding of, and ability to successfully treat, mental and substance use disorders; with a view to improving the lives of the 3 million Australians who suffer from these disorders each year.
Long-term Outcome Of Individuals Who Had A First-episode Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$1,344,905.00
Summary
The long-term illness course and outcomes of patients treated for first episode psychosis are poorly understood especially in terms of important domains such as social and vocational functioning, physical health, and quality of life. This treated cohort study of a sample of 786 patients, 15 years after their first episode of psychosis will be one of the longest and largest conducted to date. Results of the study will inform clinical practice and policy development.
The N-ICE Trial: A Randomised Controlled Trial Of The Safety And Efficacy Of N-Acetyl Cysteine (NAC) As A Pharmacotherapy For Methamphetamine (“ice”) Dependence
Funder
National Health and Medical Research Council
Funding Amount
$1,551,368.00
Summary
Crystalline methamphetamine (aka ‘ice’) is a significant public health concern in Australia and globally. Currently there are no approved medications to treat methamphetamine dependence. We will trial tN-acetyl-cysteine (NAC) as a medications for methamphetamine dependence.
Evidence-based Mental Health Planning: Translating Evidence Into Policy And Services
Funder
National Health and Medical Research Council
Funding Amount
$2,442,370.00
Summary
The CRE will design a better mental health system for Australia. This service system will include the full range of prevention and treatment interventions using the best available scientific evidence. It will also describe how to ensure that the service system is implemented, by incorporating it into government policy. The work will be carried out across 5 of the best research centres in Australia with expertise in clinical medicine, epidemiology, service planning and implementation science.
Randomised Double-blind Placebo-controlled Study Of Lisdexamfetamine For The Treatment Of Methamphetamine Dependence
Funder
National Health and Medical Research Council
Funding Amount
$1,303,735.00
Summary
Addiction to methamphetamines (‘ice’) is a growing community problem linked to serious disease and death. Current counselling approaches have limited success on their own, and more effective treatments linked to medications are needed. Lisdexamfetamine is a newly licenced stimulant medication with great promise in treating these patients. This trial will examine whether lisdexamfetamine (with counselling) safely reduces methamphetamine use and improves health and wellbeing among heavy users.
Unravelling The Behavioural And Brain Mechanisms Of Compulsive Disorders, And New Ways To Treat Them
Funder
National Health and Medical Research Council
Funding Amount
$635,076.00
Summary
Disorders of compulsion, such as obsessive-compulsive disorder and substance use disorder, are chronic, debilitating, and present a significant cost to the individual and to society. Together, these disorders affect more than 10% of the population. Moreover, 40-60% of these individuals are resistant to current treatment. The current project is aimed at improving the preclinical research underlying our understanding the behavioural and brain mechanisms of such disorders and how to treat them.